'Standalone net sales (including other operating income) of Amrutanjan Health Care for the quarter ended Mar 2024 has increased 26.65% to Rs 127.06 crore.  Operating profit margin has declined from 12.95% to 12.78%, leading to 25.02% rise in operating profit to Rs 16.24 crore.  Raw material cost as a % of total sales (net of stock adjustments) increased from 22.47% to 23.48%.   Purchase of finished goods cost fell from 27.45% to 25.17%.   Employee cost decreased from 12.59% to 10.10%.   Other expenses rose from 24.29% to 28.08%.   Selling and administration expenses rose from 7.26% to 12.32%.   Other income up 2.70% to Rs 4.95 crore.  PBIDT rose 18.98% to Rs 21.19 crore.  Provision for interest up 150% to Rs 0.05 crore.  PBDT rose 18.83% to Rs 21.14 crore.  Provision for depreciation rose 16.79% to Rs 1.53 crore. Profit before tax grew 18.99% to Rs 19.61 crore.  Provision for t...

• 

  (02-May-2025)

  Marico

  NP up 7.86%
• 

  (02-May-2025)

  Indian Overseas Bank

  Loan growth up 14%, asset quality and margin improves
• 

  (02-May-2025)

  Adani Ports & Special Economic Zone

  Net up 48% largely on higher sales, lower EO exp and higher share of profit from associates
• 

  (02-May-2025)

  Railtel Corporation of India

  Net up 46% on higher sales